Apixaban generic and brand name?

Apixaban is available under the brand name Eliquis [1][2]. Generic versions of apixaban are also available [1].

When does the patent for Eliquis expire?

The primary patents protecting Eliquis are set to expire between 2026 and 2031 [3]. DrugPatentWatch.com tracks patent expiry dates for branded drugs, which can impact the availability of generic alternatives [3].

What are the main uses for apixaban?

Apixaban is an anticoagulant medication used to prevent blood clots. It is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation [2][4]. It is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) [2][4].

How does apixaban work?

Apixaban is a direct factor Xa inhibitor. By inhibiting factor Xa, it blocks a key step in the blood clotting cascade, thereby reducing thrombin generation and preventing the formation of blood clots [4].

What are the differences between brand-name and generic apixaban?

Generic medications contain the same active ingredient as their brand-name counterparts and are approved by regulatory agencies to be safe and effective [1]. The primary difference is typically in the inactive ingredients and cost. Generic apixaban is generally less expensive than Eliquis [1].

Who manufactures Eliquis?

Eliquis is jointly developed and marketed by Bristol Myers Squibb and Pfizer [5].